Tamibarotene
98%
- Product Code: 52491
CAS:
94497-51-5
| Molecular Weight: | 351.44 g./mol | Molecular Formula: | C₂₂H₂₅NO₃ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00866188 | |
| Melting Point: | 231-232°C | Boiling Point: | 449.6°C |
| Density: | Storage Condition: | room temperature, dry |
Product Description:
Tamibarotene is primarily used in the treatment of acute promyelocytic leukemia (APL), a specific type of blood cancer. It works by inducing differentiation of leukemia cells, helping them mature into normal white blood cells, and inhibiting the growth of abnormal cells. This makes it particularly effective for patients who are resistant to or relapse after initial treatments like all-trans retinoic acid (ATRA). Additionally, it is being investigated for its potential in treating other cancers and inflammatory diseases due to its ability to modulate cell growth and immune responses. Its targeted action and efficacy in difficult-to-treat cases make it a valuable therapeutic option in oncology.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | White to off-white solid |
| PURITY | 97.5-100 |
| CARBON | 73.2 % 75.7 % |
| Infrared spectrum | Conforms to Structure |
| NMR | Consistent with structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿850.00 |
+
-
|
| 0.050 | 10-20 days | ฿2,400.00 |
+
-
|
| 0.250 | 10-20 days | ฿5,690.00 |
+
-
|
Tamibarotene
Tamibarotene is primarily used in the treatment of acute promyelocytic leukemia (APL), a specific type of blood cancer. It works by inducing differentiation of leukemia cells, helping them mature into normal white blood cells, and inhibiting the growth of abnormal cells. This makes it particularly effective for patients who are resistant to or relapse after initial treatments like all-trans retinoic acid (ATRA). Additionally, it is being investigated for its potential in treating other cancers and inflammatory diseases due to its ability to modulate cell growth and immune responses. Its targeted action and efficacy in difficult-to-treat cases make it a valuable therapeutic option in oncology.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :